Comments

Aura Biosciences Analyst Ratings

AURANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$5.85

-0.33-5.34%

At close: Dec 17, 4:00 PM EST

$5.85

N/A

After Hours: 4:00 PM EST

Overview News Earnings Options

Analyst Ratings

Insider Trades Short Interest Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$25.00

Lowest Price Target¹

$13.00

Consensus Price Target¹

$20.89

Aura Biosciences Analyst Ratings and Price Targets | NASDAQ:AURA | Benzinga

Aura Biosciences Inc has a consensus price target of $20.89 based on the ratings of 9 analysts. The high is $25 issued by HC Wainwright & Co. on March 25, 2025. The low is $13 issued by Evercore ISI Group on November 26, 2025. The 3 most-recent analyst ratings were released by Evercore ISI Group, HC Wainwright & Co., and HC Wainwright & Co. on November 26, 2025, August 13, 2025, and May 28, 2025, respectively. With an average price target of $19 between Evercore ISI Group, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 224.79% upside for Aura Biosciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Evercore ISI Group

HC Wainwright & Co.

JMP Securities

Citizens Capital Markets

¹calculated from analyst ratings

Analyst Ratings for Aura Biosciences

					Get Alert
Nov 26, 2025	122.22%	Jonathan MillerEvercore ISI Group 19%	13	Previous Current Outperform	Get Alert
Aug 13, 2025	276.07%	Andres Y. MaldonadoHC Wainwright & Co. 69%	22 22	Previous Buy Current Buy	Get Alert
May 28, 2025	276.07%	Andres MaldonadoHC Wainwright & Co. 64%	22	Previous Current Buy	Get Alert
May 23, 2025	224.79%	Jonathan WollebenJMP Securities 79%	19 19	Previous Market Outperform Current Market Outperform	Get Alert
Mar 26, 2025	224.79%	Jonathan WollebenJMP Securities 79%	19 21	Previous Market Outperform Current Market Outperform	Get Alert
Mar 26, 2025	224.79%	Jonathan WollebenCitizens Capital Markets 79%	19 21	Previous Market Outperform Current Market Outperform	Get Alert
Mar 25, 2025	327.35%	Edward WhiteHC Wainwright & Co. 47%	22 25	Previous Buy Current Buy	Get Alert
Mar 24, 2025	276.07%	Edward WhiteHC Wainwright & Co. 47%	22 22	Previous Buy Current Buy	Get Alert
Dec 5, 2024	258.97%	Jonathan WooJMP Securities 64%	21 23	Previous Market Outperform Current Market Outperform	Get Alert
Nov 14, 2024	276.07%	Edward WhiteHC Wainwright & Co. 47%	22 22	Previous Buy Current Buy	Get Alert
Oct 18, 2024	293.16%	George FarmerScotiabank 49%	20 23	Previous Sector Outperform Current Sector Outperform	Get Alert
Oct 18, 2024	310.26%	Robert HazlettBTIG 43%	21 24	Previous Buy Current Buy	Get Alert
Oct 18, 2024	276.07%	Edward WhiteHC Wainwright & Co. 47%	21 22	Previous Buy Current Buy	Get Alert
Sep 13, 2024	293.16%	Jonathan WollebenJMP Securities 79%	19 23	Previous Market Outperform Current Market Outperform	Get Alert
Sep 13, 2024	258.97%	Edward WhiteHC Wainwright & Co. 47%	21 21	Previous Buy Current Buy	Get Alert
Aug 28, 2024	224.79%	Jonathan WollebenJMP Securities 79%	19 19	Previous Market Outperform Current Market Outperform	Get Alert
Jul 25, 2024	258.97%	Edward WhiteHC Wainwright & Co. 47%	21	Previous Initiates Current Buy	Get Alert
Dec 8, 2023	258.97%	Robert HazlettBTIG 43%	21 38	Previous Buy Current Buy	Get Alert
Nov 10, 2023	224.79%	Jonathan WollebenJMP Securities 79%	19 21	Previous Market Outperform Current Market Outperform	Get Alert
Jul 27, 2023	293.16%	George FarmerScotiabank 49%	23	Previous Initiates Current Sector Outperform	Get Alert
Mar 16, 2023	327.35%	Jonathan WollebenJMP Securities 79%	25 30	Previous Current Outperform	Get Alert

FAQ

What is the target price for Aura Biosciences (AURA) stock?

The latest price target for Aura Biosciences (NASDAQ:AURA) was reported by Evercore ISI Group on November 26, 2025. The analyst firm set a price target for $13.00 expecting AURA to rise to within 12 months (a possible 122.22% upside). 8 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Aura Biosciences (AURA)?

The latest analyst rating for Aura Biosciences (NASDAQ:AURA) was provided by Evercore ISI Group, and Aura Biosciences their outperform rating.

When was the last upgrade for Aura Biosciences (AURA)?

There is no last upgrade for Aura Biosciences

When was the last downgrade for Aura Biosciences (AURA)?

There is no last downgrade for Aura Biosciences.

When is the next analyst rating going to be posted or updated for Aura Biosciences (AURA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on November 26, 2025 so you should expect the next rating to be made available sometime around November 26, 2026.

Is the Analyst Rating Aura Biosciences (AURA) correct?

While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a with a price target of $0.00 to $13.00. The current price Aura Biosciences (AURA) is trading at is $5.85, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.